These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24398797)

  • 1. Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany.
    Lobitz S; Frömmel C; Brose A; Klein J; Blankenstein O
    Eur J Hum Genet; 2014 Aug; 22(8):1051-3. PubMed ID: 24398797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
    Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for sickle cell disease: technical and legal aspects of a German pilot study with 38,220 participants.
    Frömmel C; Brose A; Klein J; Blankenstein O; Lobitz S
    Biomed Res Int; 2014; 2014():695828. PubMed ID: 25147811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
    Colombatti R; Martella M; Cattaneo L; Viola G; Cappellari A; Bergamo C; Azzena S; Schiavon S; Baraldi E; Dalla Barba B; Trafojer U; Corti P; Uggeri M; Tagliabue PE; Zorloni C; Bracchi M; Biondi A; Basso G; Masera N; Sainati L
    Pediatr Blood Cancer; 2019 May; 66(5):e27657. PubMed ID: 30724025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
    Nkya S; Mtei L; Soka D; Mdai V; Mwakale PB; Mrosso P; Mchoropa I; Rwezaula S; Azayo M; Ulenga N; Ngido M; Cox SE; D'Mello BS; Masanja H; Kabadi GS; Mbuya F; Mmbando B; Daniel Y; Streetly A; Killewo J; Tluway F; Lyimo M; Makani J
    Int Health; 2019 Nov; 11(6):589-595. PubMed ID: 31145786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns.
    Lobitz S; Klein J; Brose A; Blankenstein O; Frömmel C
    Ann Hematol; 2019 Jan; 98(1):47-53. PubMed ID: 30132072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.
    Tubman VN; Marshall R; Jallah W; Guo D; Ma C; Ohene-Frempong K; London WB; Heeney MM
    Pediatr Blood Cancer; 2016 Apr; 63(4):671-6. PubMed ID: 26739520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios.
    Allaf B; Patin F; Elion J; Couque N
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27230. PubMed ID: 29781571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Newborn screening for sickle cell disease in France].
    Brousse V; Allaf B; Benkerrou M
    Med Sci (Paris); 2021 May; 37(5):482-490. PubMed ID: 34003094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal Screening for Sickle Cell Disease in Western Andalusia: Results and Lessons Learnt after 3 Years of Implementation.
    Núñez-Jurado D; Payán-Pernía S; Álvarez-Ríos AI; Jiménez-Jambrina M; Concepcion Pérez-De-Soto I; José Palma-Vallellano A; Zapata-Bautista R; Carlos Hernández-Castellet J; Paz Garrastazul-Sánchez M; Arqueros-Martínez V; Urbano-Ramos MDM; Abdelkader-Maanan M; Raúl García-Lozano J; Delgado-Pecellín C
    Am J Perinatol; 2024 May; 41(S 01):e893-e900. PubMed ID: 36580977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening shows a high incidence of sickle cell anemia in Central India.
    Jain DL; Sarathi V; Upadhye D; Gulhane R; Nadkarni AH; Ghosh K; Colah RB
    Hemoglobin; 2012; 36(4):316-22. PubMed ID: 22712682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease.
    Moat SJ; Rees D; King L; Ifederu A; Harvey K; Hall K; Lloyd G; Morrell C; Hillier S
    Clin Chem; 2014 Feb; 60(2):373-80. PubMed ID: 24158758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neonatal screening of sickle cell disease in the Balearic Islands Autonomous Community. Pilot study in anonymous unrelated population].
    López-Escribano H; Vila Vidal M; Barceló Bennassar A; Riesco Prieto M; Ayllón Gatnau O
    An Pediatr (Barc); 2009 May; 70(5):429-33. PubMed ID: 19376755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MALDI-MS in first-line screening of newborns for sickle cell disease: results from a prospective study in comparison to HPLC.
    El Osta M; Benoist JF; Naubourg P; Bonacorsi S; Messine R; Ducoroy P; Allaf B
    Clin Chem Lab Med; 2024 May; 62(6):1149-1157. PubMed ID: 38353144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.
    Oluwole EO; Adeyemo TA; Osanyin GE; Odukoya OO; Kanki PJ; Afolabi BB
    PLoS One; 2020; 15(12):e0242861. PubMed ID: 33270733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].
    Diallo DA; Guindo A; Touré BA; Sarro YS; Sima M; Tessougué O; Baraika MA; Guindo P; Traoré M; Diallo M; Dorie A
    Rev Epidemiol Sante Publique; 2018 May; 66(3):181-185. PubMed ID: 29625861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
    Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First case of Hb Fontainebleau with sickle haemoglobin and other non-deletional α gene variants identified in neonates during newborn screening for sickle cell disorders.
    Upadhye DS; Jain D; Nair SB; Nadkarni AH; Ghosh K; Colah RB
    J Clin Pathol; 2012 Jul; 65(7):654-9. PubMed ID: 22461654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country.
    García-Morín M; Bardón-Cancho EJ; Beléndez C; Zamarro R; Béliz-Mendiola C; González-Rivera M; Vecilla C; Llorente-Otones L; Pérez-Alonso V; Román SS; Sebastián E; Dulín E; Cela E
    Ann Hematol; 2020 Jul; 99(7):1465-1474. PubMed ID: 32451712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of coverage by a neonatal screening program for hemoglobinopathies in the Recôncavo region of Bahia, Brazil].
    Silva Wdos S; Lastra A; de Oliveira SF; Klautau-Guimarães N; Grisolia CK
    Cad Saude Publica; 2006 Dec; 22(12):2561-6. PubMed ID: 17096035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.